Intra-Cellular Therapies Inc (NASDAQ:ITCI)

18.75
Delayed Data
As of 1:56pm ET
 +0.29 / +1.57%
Today’s Change
10.25
Today|||52-Week Range
25.82
+29.49%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close18.46
Today’s open18.62
Day’s range17.57 - 18.75
Volume332,366
Average volume (3 months)476,031
Market cap$1.1B
Data as of 1:56pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+21.19%
Earnings growth (this year)-57.88%
Earnings growth (next 5 years)+2.50%
Revenue growth (last year)-25.66%
P/E ratioNM
Price/Sales2,720.15
Price/Book2.50

Competitors

 Today’s
change
Today’s
% change
INSYINSYS Therapeutics I...-0.25-2.97%
ACHNAchillion Pharmaceut...-0.08-2.65%
SGYPSynergy Pharmaceutic...-0.06-3.08%
PRTKParatek Pharmaceutic...-0.23-2.08%
Data as of 2:11pm ET, 06/22/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.75
Annual revenue (last year)$245.8K
Annual profit (last year)-$97.8M
Net profit margin-39,771.64%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
Treasurer, Chief Financial &
Accounting Officer
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts